MENU
MBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MBX Biosciences (MBX) Ownership - Who owns MBX Biosciences?
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
460.59M
P/E Ratio
N/A
Total Cash
240.79M
Projected Growth
N/A
Total Debt
130K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.20
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MBX
Capitalization
461M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
241M
Total Cash/Share
7.20
Total Debt
130K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
235M
P/B Ratio
1.96
Cash Flow
N/A
Earnings
-2.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
23.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-81.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.87
Shares Held By Institutions
250M
Shares Outstanding - Current
33.4M
Total Liabilities
10.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-25.393
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information